Category: Health
-
Continuity Biosciences Awarded $9.6 Million Grant to Advance Ultra-Long-Acting Implant for HIV Prevention
Funding supports development of a subcutaneous implant designed to deliver HIV prevention medicine for multiple years from a single placement, advancing toward an IND submission and initiation of a first-in-human Phase 1 studyBRADENTON, Fla. and SEATTLE, Oct. 14, 2026 /PRNewswire/ — Continuity Bios…
-
99% of PNB MetLife's Equity Fund Assets Under Management Receive 4- or 5-Star Morningstar Ratings
NEW DELHI, Oct. 14, 2026 /PRNewswire/ — In a rapidly evolving investment landscape, customers are increasingly seeking solutions that combine protection, wealth creation and long-term financial security. Reinforcing its commitment to helping customers achieve their financial goals, PNB MetLife Indi…
-
Waters Launches AI Link, Advancing AI-Enabled LC-MS Workflows from Research to Release
Accelerates research and development by enabling AI-augmented workflows and automated lab-in-the-loop cycles, already a new and fast-growing source of demand for Waters’ instruments and consumablesLeverages Waters’ unique ability to take an AI-directed experiment from the research bench into develop…
-
Avid Organics Announces Plans for First U.S. Manufacturing Facility
Glycine and glycolic acid production targeted for 2028; up to US$50 million planned for U.S. operations through 2035AUSTIN, Texas, Oct. 13, 2026 /PRNewswire/ — Avid Organics Private Limited today announced plans to establish its first manufacturing facility outside India in the United States throug…
-
World Thrombosis Day campaign urges global action to protect women against blood clots
Global campaign brings together partners to raise awareness of women’s unique blood clot risks, recognize warning signs and take action to prevent life-threatening events.CHARLOTTE, N.C., Oct. 13, 2026 /PRNewswire/ — One in four people worldwide die from conditions caused by thrombosis, yet blood c…
-
ArkBio Announces FDA Clearance to Initiate Phase II Trial of AK0406 for Influenza Prevention
SHANGHAI, Oct. 13, 2026 /PRNewswire/ — Shanghai Ark Biopharmaceutical Co., Ltd. (“ArkBio”) today announced that the U.S. Food and Drug Administration (FDA) has granted its investigational new drug (IND) application for AK0406, a long-acting antiviral drug-Fc conjugate (AFC), enabling the company to…
-
SPARX Global Randomized Controlled Trial by Translumina Initiated to Advance Evidence for Drug-Coated Balloons in Complex Coronary Disease
LUCERNE, Switzerland and NEW DELHI, Oct. 12, 2026 /PRNewswire/ — The SPARX Global Randomized Controlled Trial (RCT) has been officially initiated, marking the launch of the multinational randomized trial evaluating a drug-coated balloon (DCB)-first strategy against contemporary drug-eluting stents …
-
Smoking Nearly Halved in Japan in a Decade: Experts at Technovation Tashkent 2026 Call for Science-Led Tobacco Policy
At the forum’s first Central Asian edition, government officials, scientists and doctors examined how countries that embraced science-led innovation have cut smoking, and what others can learnNEW DELHI, Oct. 12, 2026 /PRNewswire/ — Japan, Sweden and the United States show that giving adult smokers …
-
Canara HSBC Life Insurance Reports Healthy H1 FY27 Results: Embedded Value Reaches ₹7,622 Crore, Operating RoEV at 19.8%; Traditional Products Drive VNB Growth
New Business Premium stood at ₹1,984 crore, registering year-on-year growth of 16.1%Individual weighted premium income (WPI) of ₹1,117 crore, with year-on-year growth of 14.5%Value of New Business (VNB) stood at ₹266 crore, with year-on-year growth of 24% and new business margin of 21.3%Protection b…
-
MIDEA COMPLETES THE ACQUISITION OF ESAOTE
Midea Group marks its commitment to healthcare and innovation by completing the acquisition of Esaote GENOA, Italy, Oct. 9, 2026 /PRNewswire/ — Esaote S.p.A., a leader in the medical imaging sector, announces the completion of the controlling stake acquisition of its share capital by Midea – the C…
Latest News
About the Author
Publicize Your Brand
Through our news networks, we raise millions of users’ awareness. We are among the world’s most reputable news networks.
